IMO all the action at the moment is in rolling our Hailie to the public in the US. If you look at their site Hailie.com you will see what's going on, with Symbicort out now and 3 others to follow shortly. I am expecting an on-the-ground sales support team is necessary to support this rollout.
Like others, I think a Cap Raise is a certainty.
Ann: Appendix 4C - quarterly, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.861M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50256 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable